CIK 0001811063 · Non-accelerated filer<br>Smaller reporting company
Nuvation Bio Inc.
Sign in to watch- Ticker
- NUVB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850862255
- Phone
- 332-208-6102
- Business address
- 1 PENNSYLVANIA PLAZA, SUITE 3805, NEW YORK, NY, 10019
- Former names
- Panacea Acquisition Corp
- 8-K Event Shareholder vote results
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Planned sale CHIEF REGULATORY OFFICER sold 36,750 shares at $5.01 ($184,279)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 50,000 shares at $5.02 ($251,000)
- DEFA14A Proxy Proxy Materials
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 4 Planned sale CHIEF REGULATORY OFFICER sold 200,000 shares at $4.52 ($903,560)
- 144 Insider Sale of Securities
- 4 Derivatives Options or other derivatives
Page 2 of 20 · 400 filings